A phase I/II trial investigating weekly docetaxel and carboplatin (DC) given neoadjuvantly and then concurrently with concomitant boost radiotherapy (CB-XRT) for locally advanced squamous cell carcinoma of the head and neck

Weekly Docetaxel ◽

Concomitant Boost ◽

Boost Radiotherapy

A phase I/II trial investigating weekly docetaxel and carboplatin (DC) given neoadjuvantly and then concurrently with concomitant boost radiotherapy (CB-XRT) for locally advanced squamous cell carcinoma of the head and neck

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.5543 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5543-5543

Author(s):

D. L. Schwartz ◽

B. Yueh ◽

R. B. Montgomery ◽

M. Donahue ◽

R. Canby ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Weekly Docetaxel ◽

Concomitant Boost ◽

Boost Radiotherapy

Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck

Cancer ◽

10.1002/cncr.21085 ◽

2005 ◽

Vol 103 (12) ◽

pp. 2534-2543 ◽

Cited By ~ 15

Author(s):

David L. Schwartz ◽

R. Bruce Montgomery ◽

Bevan Yueh ◽

Michael Donahue ◽

Yoshimi Anzai ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Initial Phase ◽

Locally Advanced ◽

Weekly Docetaxel ◽

Concomitant Boost ◽

Boost Radiotherapy

Phase I trial of weekly docetaxel and cisplatin combined to concurrent external hyperfractionated irradiation in the treatment of locally advanced squamous cell carcinoma of head and neck

Radiotherapy and Oncology ◽

10.1016/s0167-8140(07)80189-7 ◽

2007 ◽

Vol 82 ◽

pp. S69

Author(s):

E. Lyraraki ◽

H. Varveris ◽

E. Petinelly ◽

J. Stratakis ◽

S. Kachris ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Locally Advanced ◽

Weekly Docetaxel

Nivolumab and Ipilimumab Combined with Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: In-field Toxicity Analysis of a Phase I Clinical Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.2289 ◽

2020 ◽

Vol 108 (3) ◽

pp. S106-S107

Author(s):

G. Manukian ◽

J. Johnson ◽

A. Luginbuhl ◽

J.M. Curry ◽

D. Cognetti ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Toxicity Analysis

970P MEDINDUCTION: Phase I trial evaluating the safety of durvalumab in combination with docetaxel, cisplatin and 5-FU (DCF) as induction therapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1085 ◽

2020 ◽

Vol 31 ◽

pp. S682-S683

Author(s):

C. Even ◽

M. Texier ◽

C. Le Tourneau ◽

R. Bahleda ◽

E. Borcoman ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Induction Therapy ◽

Phase I Trial ◽

Locally Advanced ◽

A phase I, open-label study (EGF 100262) of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Radiotherapy and Oncology ◽

10.1016/s0167-8140(07)80091-0 ◽

2007 ◽

Vol 82 ◽

pp. S30 ◽

Cited By ~ 1

Author(s):

I. El-Hariry ◽

K. Harrington ◽

J. Bourhis ◽

C. Holford

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Open Label ◽

Open Label Study ◽

Label Study

Phase I/II Study of Erlotinib Combined With Cisplatin and Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.08.079 ◽

2010 ◽

Vol 78 (3) ◽

pp. 696-702 ◽

Cited By ~ 25

Author(s):

Daniel Herchenhorn ◽

Fernando L. Dias ◽

Célia M.P. Viegas ◽

Miriam H. Federico ◽

Carlos Manoel M. Araújo ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

International Journal of Clinical Oncology ◽

10.1007/s10147-004-0390-8 ◽

2004 ◽

Vol 9 (3) ◽

Cited By ~ 16

Author(s):

Mamoru Tsukuda ◽

Yasukazu Mikami ◽

Yuji Tanigaki ◽

Hideaki Katori ◽

Choichi Horiuchi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Locally Advanced ◽

Combined Chemotherapy ◽

MEDINDUCTION: Phase I trial evaluating the safety of durvalumab in combination with Docetaxel, Cisplatin and 5-FU (DCF) in induction for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Annals of Oncology ◽

10.1093/annonc/mdx374.060 ◽

2017 ◽

Vol 28 ◽

pp. v393-v394

Author(s):

C. Even ◽

M. Texier ◽

C. Le Tourneau ◽

A. Marabelle ◽

N. Chaput ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Locally Advanced ◽

978TiP Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase I/II trial

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1093 ◽

2020 ◽

Vol 31 ◽

pp. S686

Author(s):

P. Bonomo ◽

I. Desideri ◽

M. Mangoni ◽

M. Loi ◽

C. Saieva ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽